Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach

Inflammatory Bowel Diseases

Volumn 23, Issue 4, 2017, Pages 485-493

  De Jong, Marin ^a   Van Der Meulen De Jong, Andrea ^b   Romberg Camps, Mariëlle ^c   Degens, Juliette ^a   Becx, Marco ^d   Markus, Tineke ^e   Tomlow, Henny ^a,f   Cilissen, Mia ^a   Ipenburg, Nienke ^b,f   Verwey, Marthe ^b,f   Colautti Duijsens, Laurence ^c   Hameeteman, Wim ^a   Masclee, Ad ^a   Jonkers, Daisy ^a   Pierik, Marieke ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Zuyderland Medical Centre   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e CCUVN   (Netherlands)

^f Nurses Initiative on Crohn and Colitis   (Netherlands)

Author keywords

inflammatory bowel disease; patient reported outcome measure; telemedicine

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE ACTIVITY; EMPOWERMENT; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTROENTEROLOGIST; HEALTH CARE; HOME MONITORING; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MALE; MALNUTRITION; MEDICATION COMPLIANCE; MONITORING; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SMARTPHONE; SMOKING; STRESS; TELEMEDICINE; CHRONIC DISEASE; EVALUATION STUDY; INTERPERSONAL COMMUNICATION; MENTORING; MIDDLE AGED; MOBILE APPLICATION; PATIENT SATISFACTION; PROCEDURES; PROFESSIONAL-PATIENT RELATIONSHIP; PROGRAM EVALUATION; PSYCHOLOGY; SELF CARE;

ADULT; CHRONIC DISEASE; COMMUNICATION; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; MENTORING; MIDDLE AGED; MOBILE APPLICATIONS; PATIENT SATISFACTION; PROFESSIONAL-PATIENT RELATIONS; PROGRAM EVALUATION; QUALITY OF LIFE; SELF CARE; TELEMEDICINE;

EID: 85016202560     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000001034     Document Type: Article

References (58)

1. Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:942-951.
2. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140: 1785-1794.
3. van der Valk ME, Mangen MJ, Leenders M, et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: results from the COIN study. Gut. 2014; 63:72-79.
4. Bernklev T, Jahnsen J, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005;11:909-918.
5. Zand A, van Deen WK, Inserra EK, et al. Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact. In-flamm Bowel Dis. 2015;21:1623-1630.
6. Colombel JF, Narula N, Peyrin-Biroulet L. Management strategies to improve outcomes of patients with inflammatory bowel diseases. Gastroenterology. 2017;152:351-361.e5.
7. Bodger K. Cost effectiveness of treatments for inflammatory bowel disease. Pharmacoeconomics. 2011;29:387-401.
8. Di Sabatino A, Liberato L, Marchetti M, et al. Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease. Intern Emerg Med. 2011;6(suppl 1):17-27.
9. Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol. 2009;15: 4234-4239.
10. Pedersen N, Thielsen P, Martinsen L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014;20:2276-2285.
11. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.e42; quiz e30.
12. Kemp K, Griffiths J, Campbell S, et al. An exploration of the follow-up up needs of patients with inflammatory bowel disease. J Crohns Colitis. 2013;7:e386-e395.
13. Huang VW, Reich KM, Fedorak RN. Distance management of inflammatory bowel disease: systematic review and meta-analysis. World J Gastro-enterol. 2014;20:829-842.
14. Williams JG, Cheung WY, Russell IT, et al. Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ. 2000;320:544-548.
15. Jackson BD, Gray K, Knowles SR, et al. EHealth technologies in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2016;10: 1103-1121.
16. Boyne JJ, Van Asselt AD, Gorgels AP, et al. Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure: the TEHAF-study. J Telemed Telecare. 2013;19:242-248.
17. Boyne JJ, Vrijhoef HJ, Wit R, et al. Telemonitoring in patients with heart failure, the TEHAF study: study protocol of an ongoing prospective randomised trial. Int JNurs Stud. 2011;48:94-99.
18. Rasmussen LM, Phanareth K, Nolte H, et al. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J Allergy Clin Immunol. 2005;115:1137-1142.
19. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17:535.
20. Trappenburg JC, Koevoets L, de Weert-van Oene GH, et al. Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med. 2009;9:52.
21. Bartoli L, Zanaboni P, Masella C, et al. Systematic review of telemedicine services for patients affected by chronic obstructive pulmonary disease (COPD). Telemed J E Health. 2009;15:877-883.
22. Weinstock RS, Teresi JA, Goland R, et al. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study. Diabetes Care. 2011;34:274-279.
23. Cox D, Ritterband L, Magee J, et al. Blood glucose awareness training delivered over the internet. Diabetes Care. 2008;31:1527-1528.
24. Wootton R, Geissbuhler A, Jethwani K, et al. Comparative performance of seven long-running telemedicine networks delivering humanitarian services. J Telemed Telecare. 2012;18:305-311.
25. Sutherland D, Hayter M. Structured review: evaluating the effectiveness of nurse case managers in improving health outcomes in three major chronic diseases. J Clin Nurs. 2009;18:2978-2992.
26. Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided "Constant-care" approach. Gut. 2010;59:1652-1661.
27. Keefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17:614-620.
28. Cross RK Jr. Telemanagement for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2014;10:255-257.
29. Cross RK, Cheevers N, Finkelstein J. Home telemanagement for patients with ulcerative colitis (UC HAT). Dig Dis Sci. 2009;54:2463-2472.
30. Cross RK, Cheevers N, Rustgi A, et al. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis. 2012;18:1018-1025.
31. Cross RK, Finkelstein J. Challenges in the design of a Home Telemanagement trial for patients with ulcerative colitis. Clin Trials. 2009;6:649-657.
32. Cross RK, Jambaulikar G, Langenberg P, et al. TELEmedicine for patients with inflammatory bowel disease (TELE-IBD): design and implementation of randomized clinical trial. Contemp Clin Trials. 2015;42:132-144.
33. Elkjaer M, Burisch J, Avnstrom S, et al. Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol. 2010;22:695-704.
34. Pedersen N, Elkjaer M, Duricova D, et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease. Aliment Pharmacol Ther. 2012;36:840-849.
35. Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol. 2006; 40:200-208.
36. Cross RK, Finkelstein J. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci. 2007;52:357-364.
37. Crohn en Colitis Ulcerosa Vereniging Nederland (CCUVN). Available at: www.crohn-colitis.nl. Accessed December 12, 2016.
38. Stichting mijnIBDcoach. Available at: www.stichtingmijnibdcoach.nl. Accessed December 12, 2016.
39. Sananet BV. Available at: www.sananet.nl. Accessed December 12, 2016.
40. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6; discussion 16-19.
41. Bennebroek Evertsz F, Hoeks CC, Nieuwkerk PT, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity. J Clin Gastroenterol. 2013;47:850-856.
42. Bennebroek Evertsz F, Nieuwkerk PT, Stokkers PC, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7: 890-900.
43. Falvey JD, Hoskin T, Meijer B, et al. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Inflamm Bowel Dis. 2015;21:824-831.
44. af Bjorkesten CG, Nieminen U, Turunen U, et al. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scand J Gastroenterol 2012;47:528-537.
45. de Jong M, Degans J, van den Heuvel T, Romberg-Camps M, et al. Development of a patient reported disease activity score to screen for mucosal inflammation in inflammatory bowel disease. J Crohns Colitis. 2015;9(suppl 1).
46. de Jong MJ, Jonkers DMAE, Romberg-Camps M, Bodelier AGL, et al. A combination of the Monitor IBD at Home questionnaire and a calprotectin home test as excellent screening tool for mucosal inflammation in IBD patients. United Eur Gastroenterol J. 2016;2(suppl 1).
47. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
48. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12.
49. Nursal TZ, Noyan T, Atalay BG, et al. Simple two-part tool for screening of malnutrition. Nutrition. 2005;21:659-665.
50. Kruizenga HM, Seidell JC, de Vet HC, et al. Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ). Clin Nutr. 2005;24:75-82.
51. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
52. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
53. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeco-nomics. 1993;4:353-365.
54. Irvine EJ, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571-1578.
55. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
56. Bridges KR, Sanderman R, van Sonderen E. An English language version of the social support list: preliminary reliability. Psychol Rep. 2002;90: 1055-1058.
57. Alberts M, Smets EM, Vercoulen JH, et al. "Abbreviated fatigue questionnaire": a practical tool in the classification of fatigue [in Dutch]. Ned Tijdschr Geneeskd 1997;141:1526-1530.
58. Stolwijk C, Pierik M, Landewe R, et al. Prevalence of self-reported spon-dyloarthritis features in a cohort of patients with inflammatory bowel disease. Can J Gastroenterol. 2013;27:199-205.